ECM
ZBH icon

ExodusPoint Capital Management’s Zimmer Biomet ZBH Stock Holding History

ExodusPoint Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-30,900
Closed -$3.58M – 2293
2020
Q2 		$3.58M Buy
+30,900
New +$3.56M 0.09% 236

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ExodusPoint Capital Management's ZBH Position: Q1 2026 in Review

ExodusPoint Capital Management increased its Zimmer Biomet (ZBH) stake by 459% in Q1 2026, buying an estimated $7.28M and bringing the position to 96,600 shares worth $8.73M. The position accounts for 0.07% of the portfolio, ranked #264.

ExodusPoint Capital Management first reported a position in ZBH in Q4 2018 and has held it in 21 quarters since. The position peaked at $39M in Q4 2023. 913 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • ExodusPoint Capital Management held 96,600 shares of Zimmer Biomet worth $8.73M as of Q1 2026.
  • ExodusPoint Capital Management bought 79,305 Zimmer Biomet shares in Q1 2026, an estimated $7.28M.
  • Zimmer Biomet made up 0.07% of ExodusPoint Capital Management's portfolio in Q1 2026, its #264 holding.
  • ExodusPoint Capital Management first reported a position in Zimmer Biomet in Q4 2018 and has held it in 21 quarters since.
  • ExodusPoint Capital Management's Zimmer Biomet position peaked at $39M in Q4 2023.
  • 913 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.